Value-Based Cancer Care: Paying for Performance

William G. Nelson, MD, PhD, Editor-in-Chief of Cancer Today magazine, discusses the merits of value-based programs that reward health care providers for the quality of care they give to patients.

AACR in the News

Dr. Stephen Hahn formally nominated to be next FDA commissioner

AACR's CEO, Margaret Foti, PhD, MD (hc), praised Stephen Hahn, MD, President Trump's nominee for commissioner of the FDA. According to CNN, she said Hahn is "esteemed for the breadth and depth of his scientific knowledge and expertise." Hahn is a member of the AACR.